DTC meeting planned
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to hold a public hearing on direct-to-consumer promotion of medical products, including medical devices, Nov. 1-2 in Washington, D.C. "Medical device DTC promotion has not yet received as much FDA attention because, until recently, there has not been a significant amount of DTC device promotion," the agency notes in a Sept. 13 Federal Register notice. FDA points to "recent increases in DTC device promotion and a growing awareness among consumers that medical devices may give them important choices." Those interested in participating must contact FDA by Oct. 11...
You may also be interested in...
Firms Should Heed Where Third-Party Web Links Are Posted – FDA’s Wolf
Firms providing access to independent websites should provide the links on centralized corporate pages rather than on product-specific Internet sites, FDA's Office of Compliance staffer Deborah Wolf suggested Sept. 20
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.